With more than 1,600 proven clinical studies, Olympus continues to innovate and partner with pulmonologists to offer patients the gold standard in diagnosis and staging lung cancer. The BF-UC190F, the next generation of Olympus EBUS bronchoscope, provides enhanced access and control to allow staging and diagnosis of even difficult-to-reach lymph nodes and lesions.
- Real-time sampling: Real-time ultrasound imaging enables direct visualization of the ViziShot 2 EBUS-TBNA needle as it penetrates the lymph node. This facilitates correct capsule-to-capsule technique, which helps to optimize sample collection.
- Advancing airway access: The uniquely designed compact distal tip of the BF-UC190F and increased scope angulation enhances maneuverability with better access to difficult-to-reach lymph node stations in the mediastinum (4L) and in the hilum (10R). A decreased forward oblique angle of 20° facilitates easier endoscopic orientation and allows the operator to keep the endoscopic image in full field of view while navigating the airways during a procedure.
- Advancing precision: A steeper needle puncture angle provides a more perpendicular needle orientation toward the target allowing for smoother target penetration between cartilage rings and other critical vessels. An improved endoscopic image with higher resolution provides better visualization in the airway to accurately identify anatomy landmarks and detect abnormalities.
- Advancing versatility: The power of the EVIS EXERA III platform expands across the hospital to enable equipment standardization and simplified support and service, with the ultimate goal of lowering the total cost of equipment. The BF-UC190F has a working channel of 2.2 mm that is compatible with a full line-up of Olympus EBUS-TBNA needles which are designed to deliver outstanding performance while minimizing channel damage, thereby potentially reducing repair costs and extending endoscope life.